Roy D. Baynes – Insider Trading Activity | DataHeimdall

Roy D. Baynes

Director at Travere Therapeutics, Inc.

CIK: 1680739

8

Total trades

0

Buys

3

Sells

Apr 14, 2026

Last trade

Date	Stock	Type	Shares	Value	Src
Apr 14, 2026	TVTXTravere Therapeutics, Inc.	Option	6,750	$115K
Apr 14, 2026	TVTXTravere Therapeutics, Inc.	Option	9,000	$139K
Apr 14, 2026	TVTXTravere Therapeutics, Inc.	Option	4,500	$82K
Apr 14, 2026	TVTXTravere Therapeutics, Inc.	Sell	26,000	$1.1M
Apr 14, 2026	TVTXTravere Therapeutics, Inc.	Sell	6,750	$284K
Apr 14, 2026	TVTXTravere Therapeutics, Inc.	Option	8,000	$144K
Apr 6, 2026	TVTXTravere Therapeutics, Inc.	Option	10,000	$265K
Apr 6, 2026	TVTXTravere Therapeutics, Inc.	Sell	10,000	$330K